电子邮件 | tki***@***.com | 获取Email |
---|
电子邮件 | tki***@***.com | 获取Email |
---|
EpiVario is a preclinical stage biotechnology company focusing on neuropsychiatric disorders. Our co-founders, Dr. Shelley Berger and Dr. Philipp Mews, are leaders in the field of neuroepigenetics. They identified a key metabolic enzyme that functions within the nucleus of neurons to activate genes critical for long term memory. This epigenetic mechanism plays a critical role in consolidating trauma-induced fear and stress responses and drug craving associated with addiction. Thus, providing a new target for treating memory-related neuropsychiatric disorders, such as PTSD and drug and alcohol addiction, and starting with nicotine addiction. An Expert Team Founded by epigeneticists at the University of Pennsylvania, EpiVario's team leverages deep expertise in epigenetics and neuroscience, along with the commercialization of novel drugs. EpiVario's co-founders are known and respected leaders in their fields, with more than 30 years of combined experience. A Strong Intellectual Property Portfolio EpiVario currently has PCT and U.S. patents pending, both related to the Company's novel approach to targeting the ACSS2 gene. About Addiction and PTSD PTSD is a psychiatric disorder that can develop as a response to experiencing or witnessing a traumatic event, such as interpersonal violence, combat, or a life-threatening accident or natural disaster. Core features of PTSD include re-experiencing symptoms (i.e., intrusive memories, flashbacks, and nightmares), avoidance of reminders of the trauma, negative thoughts and feelings (e.g., amnesia for aspects of the trauma, anhedonia, withdrawal, exaggerated self-blame), and increased arousal (i.e., insomnia, irritability, poor concentration, hypervigilance). The severity of PTSD symptoms can intensify through cycles of memory recall and reconsolidation.
公司 | EpiVario, Inc. |
---|---|
职位 | President and CEO |
地点 | United States |
http://www.linkedin.com/in/tskim1tskim | |
部门 | c_suite |
头衔 | President and CEO at EpiVario, Inc. |
Georgia Institute of Technology Advisory Board
2020-04-01 -
EpiVario, Inc. President and CEO
2018-03-01 -
President
2017-12-01 -
INOVIO Pharmaceuticals, Inc. General Counsel and Corporate Secretary
2009-10-01 - 2017-11-01
INOVIO Pharmaceuticals, Inc. Senior Director Intellectual Property
2009-06-01 - 2009-10-01
Thomas Kim 在 EpiVario, Inc. 担任 President and CEO at EpiVario, Inc.
Thomas Kim 在 EpiVario, Inc. 的职位是 President and CEO at EpiVario, Inc.
Thomas Kim 的电子邮件地址是 tki***@***.com
Thomas Kim 的电话号码是 -
Thomas Kim 的公司电话号码是 +121****
Thomas Kim 在 research 工作。
Thomas Kim 的一些同事包括Philipp Mews、Thomas KimLesley Chaboub、。
Thomas Kim联系方式: 电子邮件地址:tki***@***.com 电话号码:-
Thomas Kim 的个人领英是:http://www.linkedin.com/in/tskim1tskim
Thomas Kim 的办公地点:3401 grays ferry avenue, philadelphia, pennsylvania, united states, 19146
Top-ranked on G2 Crowd
全球B2B企业库 海关贸易数据 展会采购数据
全球B2B企业库
海关贸易数据
展销采购数据
Top-ranked on G2 Crowd